COMPOUND FOR ATTENUATION OF MECAMYLAMINE-PRECIPITATED NICOTINE DEPENDENCE WITHDRAWAL SYNDROME

The present disclosure relates generally to the field of pharmaceuticals. Specifically, thepresent disclosure is directed to a compound ML-141 for the treatment, amelioration orprevention of mecamylamine-induced precipitation of nicotine dependence withdrawalsyndrome.

Inventors

GURJEET THAKUR, IMRAAN RATHER, SONIA DHIMAN

Patent File Number - 202011026270        Patent File Date - 22/06/2020